milrinone has been researched along with Blood Poisoning in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combination therapy with milrinone and esmolol could improve cardiac function and the 28-day survival rate in patients with severe sepsis." | 9.20 | Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. ( Guo, J; Nie, X; Wang, Z; Wu, Q; Yang, C, 2015) |
| "To characterize the effect of the phosphodiesterase inhibitor (PDEI) milrinone in adult patients with a non-hyperdynamic condition during the course of the systemic inflammatory response syndrome (SIRS) or sepsis when compared with patients with congestive heart failure (CHF)." | 9.09 | IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. ( Delle Karth, G; Frossard, M; Geppert, A; Gschwandtner, ME; Heinz, G; Neunteufl, T; Reinelt, P; Siostrzonek, P; Zauner, C, 1999) |
| "In addition to the positive inotropic effects of milrinone, its immunomodulatory properties that result in decreased cytokine storm can be beneficial during early period of sepsis." | 8.12 | Early administration of milrinone ameliorates lung and kidney injury during sepsis in juvenile rats. ( Bilen, A; Halici, H; Halici, Z; Keskin, H; Kose, D; Mendil, AS; Ozkaraca, M; Tavaci, T; Yuksel, TN, 2022) |
| "Compared with dobutamine, the use of milrinone did not decrease hospital mortality in patients with sepsis." | 8.02 | The effect of dobutamine vs milrinone in sepsis: A big data, real-world study. ( Wei, J; Ye, X; Yin, H; Zhang, R; Zhu, Y, 2021) |
| " We weighed the effects of dobutamine and milrinone as inotropes in mice with cecal ligation and puncture (CLP)-induced polymicrobial sepsis." | 7.85 | Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation. ( Hattori, K; Hattori, Y; Matsuda, N; Palikhe, S; Sakai, M; Suzuki, T; Tomita, K; Yamashita, S; Yoshimura, N, 2017) |
| "Combination therapy with milrinone and esmolol could improve cardiac function and the 28-day survival rate in patients with severe sepsis." | 5.20 | Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. ( Guo, J; Nie, X; Wang, Z; Wu, Q; Yang, C, 2015) |
| "To characterize the effect of the phosphodiesterase inhibitor (PDEI) milrinone in adult patients with a non-hyperdynamic condition during the course of the systemic inflammatory response syndrome (SIRS) or sepsis when compared with patients with congestive heart failure (CHF)." | 5.09 | IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. ( Delle Karth, G; Frossard, M; Geppert, A; Gschwandtner, ME; Heinz, G; Neunteufl, T; Reinelt, P; Siostrzonek, P; Zauner, C, 1999) |
| "In addition to the positive inotropic effects of milrinone, its immunomodulatory properties that result in decreased cytokine storm can be beneficial during early period of sepsis." | 4.12 | Early administration of milrinone ameliorates lung and kidney injury during sepsis in juvenile rats. ( Bilen, A; Halici, H; Halici, Z; Keskin, H; Kose, D; Mendil, AS; Ozkaraca, M; Tavaci, T; Yuksel, TN, 2022) |
| "Compared with dobutamine, the use of milrinone did not decrease hospital mortality in patients with sepsis." | 4.02 | The effect of dobutamine vs milrinone in sepsis: A big data, real-world study. ( Wei, J; Ye, X; Yin, H; Zhang, R; Zhu, Y, 2021) |
| " We weighed the effects of dobutamine and milrinone as inotropes in mice with cecal ligation and puncture (CLP)-induced polymicrobial sepsis." | 3.85 | Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation. ( Hattori, K; Hattori, Y; Matsuda, N; Palikhe, S; Sakai, M; Suzuki, T; Tomita, K; Yamashita, S; Yoshimura, N, 2017) |
| " As treatment, three inotropes commonly used for treatment of cardiac failure were infused for 45 mins in separate animal groups-milrinone, dobutamine, and levosimendan." | 3.74 | Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. ( Barraud, D; Damy, T; Faivre, V; Gayat, E; Heymes, C; Mebazaa, A; Payen, D; Shah, AM; Welschbillig, S, 2007) |
| "Purpura fulminans is a severe and rapidly progressive septic process characterised by the development of haemorrhagic and ecchymotic lesions and skin necrosis." | 1.51 | Management of purpura fulminans skin lesions in a premature neonate with sepsis: a case study. ( Bosch-Alcaraz, A; Manzano-Canillas, ML; Pérez-Acevedo, G; Torra-Bou, JE, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kurup, V | 1 |
| Simpson, RS | 1 |
| Keskin, H | 1 |
| Tavaci, T | 1 |
| Halici, H | 1 |
| Yuksel, TN | 1 |
| Ozkaraca, M | 1 |
| Bilen, A | 1 |
| Kose, D | 1 |
| Mendil, AS | 1 |
| Halici, Z | 1 |
| Zhu, Y | 1 |
| Yin, H | 1 |
| Zhang, R | 1 |
| Ye, X | 1 |
| Wei, J | 1 |
| Sakai, M | 2 |
| Suzuki, T | 2 |
| Tomita, K | 2 |
| Yamashita, S | 2 |
| Palikhe, S | 1 |
| Hattori, K | 2 |
| Yoshimura, N | 2 |
| Matsuda, N | 2 |
| Hattori, Y | 2 |
| Iguchi, K | 1 |
| Sakamoto, T | 1 |
| Yokoo, H | 1 |
| Misawa, H | 1 |
| Nagata, T | 1 |
| Watanabe, Y | 1 |
| Pérez-Acevedo, G | 1 |
| Torra-Bou, JE | 1 |
| Manzano-Canillas, ML | 1 |
| Bosch-Alcaraz, A | 1 |
| Wang, Z | 1 |
| Wu, Q | 1 |
| Nie, X | 1 |
| Guo, J | 1 |
| Yang, C | 1 |
| Schmittinger, CA | 1 |
| Dünser, MW | 1 |
| Haller, M | 1 |
| Ulmer, H | 1 |
| Luckner, G | 1 |
| Torgersen, C | 1 |
| Jochberger, S | 1 |
| Hasibeder, WR | 1 |
| Mrabat, H | 1 |
| Beagle, J | 1 |
| Hang, Z | 1 |
| Garg, HG | 1 |
| Hales, CA | 1 |
| Quinn, DA | 1 |
| Rich, N | 1 |
| West, N | 1 |
| McMaster, P | 1 |
| Alexander, J | 1 |
| Barraud, D | 1 |
| Faivre, V | 1 |
| Damy, T | 1 |
| Welschbillig, S | 1 |
| Gayat, E | 1 |
| Heymes, C | 1 |
| Payen, D | 1 |
| Shah, AM | 1 |
| Mebazaa, A | 1 |
| Heinz, G | 1 |
| Geppert, A | 1 |
| Delle Karth, G | 1 |
| Reinelt, P | 1 |
| Gschwandtner, ME | 1 |
| Neunteufl, T | 1 |
| Zauner, C | 1 |
| Frossard, M | 1 |
| Siostrzonek, P | 1 |
2 trials available for milrinone and Blood Poisoning
| Article | Year |
|---|---|
Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Female | 2015 |
IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mil | 1999 |
10 other studies available for milrinone and Blood Poisoning
| Article | Year |
|---|---|
Sepsis-induced digital ischaemia in a professional pianist, in the absence of vasopressors.
Topics: Adult; Amputation, Surgical; Anticoagulants; Diagnosis, Differential; Fingers; Gangrene; Heparin; Hu | 2019 |
Early administration of milrinone ameliorates lung and kidney injury during sepsis in juvenile rats.
Topics: Animals; Disease Models, Animal; Kidney; Ligation; Lung; Milrinone; Punctures; Rats; Sepsis | 2022 |
The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.
Topics: Big Data; Cardiotonic Agents; Dobutamine; Humans; Milrinone; Retrospective Studies; Sepsis | 2021 |
Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.
Topics: Adenylyl Cyclases; Animals; Cardiotonic Agents; Cecum; Cyclic AMP; Cyclic Nucleotide Phosphodiestera | 2017 |
Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis.
Topics: Animals; Calcium; Cardiotonic Agents; Cecum; Cytokines; Ligation; Male; Mice, Inbred BALB C; Milrino | 2018 |
Management of purpura fulminans skin lesions in a premature neonate with sepsis: a case study.
Topics: Debridement; Diagnosis, Differential; Female; Humans; Infant, Newborn; Infant, Premature; Infusions, | 2019 |
Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression.
Topics: Aged; Aged, 80 and over; Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Male; Metoprol | 2008 |
Inhibition of HA synthase 3 mRNA expression, with a phosphodiesterase 3 inhibitor, blocks lung injury in a septic ventilated rat model.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Capillary Permea | 2009 |
Milrinone in meningococcal sepsis.
Topics: Child; Humans; Intensive Care Units, Pediatric; Leg; Meningococcal Infections; Milrinone; Phosphodie | 2003 |
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Dobutamine; Heart Failure; Hydrazones | 2007 |